You are here

  • Home
  • Archive
  • Volume 7, Issue 3
  • Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study

Citation Tools

Article menu

Download PDFPDF

Infections
Original research
Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Janssen MT, Ramiro S, Mostard RL, et al
Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study
RMD Open 2021;7:e001906. doi: 10.1136/rmdopen-2021-001906